CClinicalTrials.gg
Status unknownNCT02866188TFSRCASWUpdated Aug 15, 2016

The Feasibility Study of Recognition of Cardiac Arrest Using a Smart Watch

An observational study in Cardiac Arrest, sponsored by Hanyang University. Status unknown at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-15.

Sponsored by Hanyang University · Observational

The sponsor has not verified this record recently (last verified Aug 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

In this study, we want to find out whether the recognition of cardiac arrest using a smart watch is feasible or not. If this idea is possible, the recognition of cardiac arrest using the smart watch is easy and fast to the witness, like a general person. By using the smart watch, the emergency response system for cardiac arrest and the bystander CPR or BLS is beginning earlier than using conventional cardiac arrest recognition method in field.

Read the detailed description

In Korea, an out-of-hospital cardiac arrest (OHCA) was occurred twenty thousand person per year, and among them sixty percent was occurred in their home. We already knew that a survivor rate and neurological outcome of OHCA patient has a close relation with initial emergency management in field, like a bystander cardiopulmonary resuscitation (CPR), Basic Life Support (BLS), etc. However, in Korea, a witness almost did not the bystander CPR or BLS in field until highly trained rescuers arrived there. So, total survivor rate is just 2.4 % irrespective of neurologic outcome in Korea.

Generally, in Korea, a beginning of the bystander CPR progress throughout dispatcher's instruction of emergency response system. This system for OHCA patient activate only when the witness recognize cardiac arrest and call the emergency response system. Therefore, cardiac arrest recognition by the witness is very important.

However, a conventional recognition of cardiac arrest in field is often difficult, because there are no monitoring devices, healthcare providers. The conventional recognition method of cardiac arrest is that it is firstly to check mental status, secondly check pulse on patient's carotid artery and self-respiration. This method is too difficult for the witness, especially general persons. Even, it is difficult for an emergency physicians, too.

Consequentially, the recognition of cardiac arrest by the witness is generally delayed, a golden-time is running out until highly trained rescuers arrive there. An average arrival time of highly trained rescuers is eight to ten minutes. A hypoxic brain damage is begin from four minutes after cardiac arrest. As a result, this delayed time is already passed four minutes after cardiac arrest. So, the survivor rate and the neurologic outcome are not good enough.

In this study, we want to find out whether the recognition of cardiac arrest using a smart watch is feasible or not. If this idea is possible, the recognition of cardiac arrest using the smart watch is easy and fast to the witness, like a general person. By using the smart watch, the emergency response system for cardiac arrest and the bystander CPR or BLS is beginning earlier than using conventional cardiac arrest recognition method in field.

02

Conditions studied

  • Cardiac Arrest

Browse trials for

03

In context

Heart Arrest

966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's planned enrollment of 50 is below the median of 200 across 383 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Hanyang University is the lead sponsor of 51 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Shock or Cardiac arrest patients in emergency room.

Inclusion criteria

  • Over 18 years old
  • Shock
  • Cardiac arrest

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • DeviceCheck pulse with Smart watch on 3 parts of patient's body surface

    Check pulse with smart watch on wrist, carotid artery, and eye of patients in shock or cardiac arrest state.

06

What researchers measure

Primary outcomes

  1. The minimum blood pressure on wrist

    mmHg, Blood pressure in minimum checkable pulse using smart watch

    Time frame: 10 seconds

  2. The minimum blood pressure on carotid artery

    mmHg, Blood pressure in minimum checkable pulse using smart watch

    Time frame: 10 seconds

  3. The minimum blood pressure on eye

    mmHg, Blood pressure in minimum checkable pulse using smart watch

    Time frame: 10 seconds

07

Study locations

1 site
  • Hanyang University Guri Hospital
    Guri-si, Gyeonggi-do 471-701, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02866188
Lead sponsor
Hanyang University
Responsible party
LEE YOON-JE (Emergency physician, Hanyang University) — Principal investigator
First posted
Aug 15, 2016
Start date
Aug 2016
Primary completion
Nov 2016 (estimated)
Completion
Dec 2016 (estimated)
Last update
Aug 15, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion